Advanced Medical Technology Association
FDANonrulemakingFDA-2022-D-1385

Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; Availability

RIN
Last modified
Nov 18, 2025
Comment window
closed 1399d ago
Advanced Medical Technology Association filings
1

Activity

Advanced Medical Technology Association filed 1 comment on this docket between Sep 26, 2022 and Sep 26, 2022. 0 other organizations filed here. The comment window closed 1399d ago.

What Advanced Medical Technology Association filed (1)

Sep 26, 2022· Comment from Advanced Medical Technology Association (AdvaMed)· FDA-2022-D-1385-0010

Filed on regulations.gov — full text not in the inline record.

Abstract

No abstract recorded.

View on regulations.gov →
Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; Availability (FDA) — Advanced Medical Technology Association | OpenPolis